Donepezil and Memantine in Moderate to Severe Alzheimer's Disease.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Donepezil (Primary) ; Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms DOMINO-AD
- 22 Aug 2013 Accrual to date is 37% according to United Kingdom Clinical Research Network record.
- 08 Mar 2012 Results published in the New England Journal of Medicine.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).